Trials / Recruiting
RecruitingNCT03826693
Efficacy of Nitrous Oxide in OCD: Pilot Study
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study investigates whether the commonly used and well-tolerated inhaled anesthetic nitrous oxide can rapidly improve symptoms of OCD.
Detailed description
Obsessive-compulsive disorder (OCD) is a chronic and disabling disorder characterized by recurrent intrusive thoughts and associated compulsive behaviors that is estimated to affect more than 3 million individuals in the US each year. This study seeks to explore whether a single inhalation of nitrous oxide gas may bring about rapid symptom relief in OCD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nitrous Oxide | OCD participants in this arm will receive 50%oxygen/50% nitrous oxide admixture for 60 minutes. |
| DRUG | Nitrogen | OCD participants in this arm will receive 50%oxygen/50% nitrogen admixture for 60 minutes. |
Timeline
- Start date
- 2021-04-17
- Primary completion
- 2026-09-01
- Completion
- 2027-10-01
- First posted
- 2019-02-01
- Last updated
- 2025-08-27
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03826693. Inclusion in this directory is not an endorsement.